178 related articles for article (PubMed ID: 12493261)
1. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
[TBL] [Abstract][Full Text] [Related]
2. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
Eur J Haematol; 2004 Apr; 72(4):259-63. PubMed ID: 15089763
[TBL] [Abstract][Full Text] [Related]
3. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12.
Zhang LY; Ibbotson RE; Orchard JA; Gardiner AC; Seear RV; Chase AJ; Oscier DG; Cross NC
Leukemia; 2003 Nov; 17(11):2097-100. PubMed ID: 12931211
[TBL] [Abstract][Full Text] [Related]
4. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study.
Wiley JS; Dao-Ung LP; Gu BJ; Sluyter R; Shemon AN; Li C; Taper J; Gallo J; Manoharan A
Lancet; 2002 Mar; 359(9312):1114-9. PubMed ID: 11943260
[TBL] [Abstract][Full Text] [Related]
5. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
Tobin G
Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
[TBL] [Abstract][Full Text] [Related]
6. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia.
Sellick GS; Rudd M; Eve P; Allinson R; Matutes E; Catovsky D; Houlston RS
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1065-7. PubMed ID: 15184265
[TBL] [Abstract][Full Text] [Related]
7. The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C
Br J Haematol; 2003 Oct; 123(1):66-71. PubMed ID: 14510944
[TBL] [Abstract][Full Text] [Related]
8. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
[TBL] [Abstract][Full Text] [Related]
9. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
10. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R
Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062
[TBL] [Abstract][Full Text] [Related]
11. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
[TBL] [Abstract][Full Text] [Related]
12. The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
Leukemia; 2006 Jan; 20(1):77-81. PubMed ID: 16307023
[TBL] [Abstract][Full Text] [Related]
13. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia.
Dao-Ung LP; Fuller SJ; Sluyter R; SkarRatt KK; Thunberg U; Tobin G; Byth K; Ban M; Rosenquist R; Stewart GJ; Wiley JS
Br J Haematol; 2004 Jun; 125(6):815-7. PubMed ID: 15180873
[No Abstract] [Full Text] [Related]
14. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
Fernando SL; Saunders BM; Sluyter R; Skarratt KK; Goldberg H; Marks GB; Wiley JS; Britton WJ
Am J Respir Crit Care Med; 2007 Feb; 175(4):360-6. PubMed ID: 17095747
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the P2X7 1513A/C loss-of-function polymorphism to extrapulmonary tuberculosis susceptibility in Tunisian populations.
Ben-Selma W; Ben-Kahla I; Boukadida J; Harizi H
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):65-72. PubMed ID: 21635566
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunoglobulin variable heavy chain gene mutation status: long term follow-up in a series of chronic lymphocytic leukemia patients.
Panovska-Stavridis I; Cevreska L; Stojanovic A; Efremov D
Prilozi; 2006 Dec; 27(2):127-37. PubMed ID: 17211297
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
[TBL] [Abstract][Full Text] [Related]
18. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis.
Singla N; Gupta D; Joshi A; Batra N; Singh J
Int J Tuberc Lung Dis; 2012 Feb; 16(2):224-9. PubMed ID: 22137490
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
